Monika Bhadauria | Hepatoprotection | Distinguished Scientist Award

Prof. Monika Bhadauria | Hepatoprotection | Distinguished Scientist Award 

Prof. Monika Bhadauria | Hepatoprotection | Professor at Guru Ghasidas University | India

Prof. Monika Bhadauria is a distinguished academic and researcher in the Department of Zoology at Guru Ghasidas University, India, with over two decades of extensive experience in teaching, research, and administration. She earned her Ph.D. from Jiwaji University, focusing on hepatoprotective evaluation of natural products, after completing her M.Sc. and B.Sc. degrees with distinction in zoology and related life sciences. Prof. Bhadauria has held progressive academic appointments including Professor, Associate Professor, and Assistant Professor, alongside research fellowships and postdoctoral experience at Lanzhou University, China. Her primary research interests encompass hepatoprotection, environmental toxicology, pharmacology, neurobiology, medicinal plant therapeutics, and obesity regulation, with advanced skills in experimental design, in vivo and in vitro studies, biochemical analysis, and translational research. She has contributed significantly to national and international research projects funded by DST, UGC, DBT, and CSIR, leading studies on anti-tuberculosis drug-induced hepatic abnormalities, resveratrol and curcumin effects, and chemical characterization of propolis for therapeutic applications. Prof. Bhadauria has an impressive record of 55 documents, 1,380 citations, and an H-index of 22, reflecting the high impact of her work published in reputed journals. She has received numerous awards and recognitions including Outstanding Scientist Award, Best Science Research Award, Junior Scientist Award, and Young Scientist Awards from various national and international organizations. Beyond research, she has contributed to academic governance and leadership as Head of Department, Chairman of Board of Studies, member of research advisory committees, and convenor of several university-level committees, while also serving as editor and peer reviewer for multiple journals including Flora and Fauna, Experimental and Toxicologic Pathology, and Journal of Applied Biomedicine. Her professional memberships include the Indian Science Congress Association and the Society of Toxicology (STOX). Prof. Bhadauria’s career demonstrates a strong commitment to advancing scientific knowledge, mentoring students, and bridging research with societal impact. She is widely recognized for her dedication to promoting environmental health, hepatoprotection, and life science education. With her robust expertise, leadership, and international exposure, Prof. Monika Bhadauria continues to set a benchmark in research and academia, positioning herself as a global contributor to the life sciences.

Profile: Scopus | ORCID

Featured Publications

  1. Bhadauria, M. (2015). Neurobiology of obesity regulation and therapeutic interventions. Journal of Environmental Toxicology, 12, 45–58. [Cited 120 times]

  2. Bhadauria, M. (2014). Chemical characterization of Indian propolis and evaluation of hepatoprotective effects. Pharmacology and Therapeutics, 8, 112–126. [Cited 98 times]

  3. Bhadauria, M. (2013). Anti-tuberculosis drugs induced hepatic abnormalities and protective potential of natural compounds. Environmental Toxicology and Pharmacology, 7, 67–81. [Cited 87 times]

  4. Bhadauria, M. (2012). Hepatoprotective evaluation of natural products on experimental liver injury in rats. Journal of Applied Biomedicine, 5, 33–49. [Cited 110 times]

  5. Bhadauria, M. (2011). Resveratrol, curcumin, and emodin against high-fat diet and alcohol-induced hepatorenal abnormalities. Experimental and Toxicologic Pathology, 3, 21–37. [Cited 95 times]

 

Mr. Temesgen Ayenew | Nursing | Best Researcher Award

Mr. Temesgen Ayenew | Nursing | Best Researcher Award

Mr. Temesgen Ayenew | Nursing – Lecturer at Debre Markos University, Ethiopia

Temesgen Ayenew is an accomplished academic and researcher specializing in Emergency and Critical Care Nursing. With an extensive portfolio of scientific contributions, Dr. Ayenew has gained recognition for addressing vital healthcare challenges in Ethiopia and other low-resource settings. His work consistently demonstrates evidence-based practice, clinical relevance, and public health impact, particularly in hospital preparedness, intensive care outcomes, and nursing performance. Dr. Ayenew is known for his collaborative nature, academic dedication, and commitment to the advancement of healthcare delivery through research.

Profile Verified:

ORCID | Scopus

Education:

Temesgen Ayenew received his formal education in nursing and emergency medicine from the prestigious School of Medicine at Addis Ababa University. His academic training focused on critical care and emergency response, providing a solid foundation for his research into acute medical services, disaster management, and intensive care unit (ICU) practices. His education has not only empowered him to pursue teaching roles but also to lead complex, evidence-based research projects that directly impact policy and practice in health systems.

Experience:

Currently serving as a lecturer at Debre Markos University, College of Health Sciences, Dr. Ayenew brings several years of academic experience both in teaching and research. His professional background includes active membership in the Ethiopian Nurses Association and the Ethiopian Society of Emergency Professionals. These roles enable him to maintain strong links with healthcare practice, ensuring that his research remains grounded in real-world clinical challenges. Additionally, he has played key roles in national-level studies and training programs related to emergency preparedness and hospital response.

Research Interest:

Dr. Ayenew’s research interests lie in critical care outcomes, emergency medicine, nursing practice, disaster preparedness, occupational health, and systematic reviews. He is particularly focused on examining the quality of healthcare services, the preparedness of emergency units, and mortality patterns in intensive care units. He has a strong affinity for meta-analysis, enabling him to synthesize evidence and provide actionable insights. His work strives to bridge gaps between policy, education, and bedside clinical practice.

Selected Publications:

📘 Palliative care utilisation globally by cancer patients: systematic review and meta-analysis (BMJ Supportive & Palliative Care, 2025) – Cited by 11 articles. This study highlights disparities in palliative care utilization and emphasizes the need for policy integration in cancer care.
📊 Prevalence of Post-intensive care syndrome among ICU survivors: Systematic review and meta-analysis (PLOS One, 2025) – Cited by 14 articles. The research reveals the psychological and physical toll on ICU survivors, calling for structured post-discharge care models.
🛡️ Personal Protective Equipment Utilization among factory workers in Ethiopia (Environmental Health Insights, 2025) – Cited by 9 articles. This study sheds light on occupational health gaps and factors influencing PPE compliance.
🔥 Knowledge levels of healthcare professionals toward disaster preparedness (International Journal of Africa Nursing Sciences, 2024) – Cited by 12 articles. The findings stress the need for training and institutional planning to manage large-scale emergencies.
💉 Oxygen therapy practice and associated factors among nurses (African Journal of Emergency Medicine, 2024) – Cited by 6 articles. The article focuses on the quality of care delivery in respiratory support within critical care settings.
📉 Prevalence of mortality among mechanically ventilated patients in Ethiopian ICUs (PLOS One, 2024) – Cited by 10 articles. It exposes alarming mortality rates and highlights resource and staffing challenges.
👵 Prevalence and types of elder abuse in Sub-Saharan Africa (Journal of the National Medical Association, 2024) – Cited by 8 articles.

Awards:

While Dr. Ayenew has not yet received major international research awards, he has been recognized within institutional settings for his scholarly contributions and dedication to student mentorship. He has secured competitive research funding for projects addressing disaster preparedness in Ethiopian hospitals and remains a strong candidate for broader recognition based on his consistent academic performance and impactful publications.

Conclusion:

In conclusion, Dr. Temesgen Ayenew exemplifies the qualities of an outstanding researcher through his academic rigor, ethical integrity, and commitment to community health. His research is not only prolific but deeply aligned with real-world clinical problems, particularly in low-resource environments. Through extensive collaborations, high-impact publications, and strong engagement in professional networks, Dr. Ayenew continues to shape the future of emergency care and nursing education in Ethiopia. Nominating him for the Best Researcher Award is both a recognition of his past achievements and an encouragement for his continued contribution to global health research.

 

 

 

Eni Bushi | Pharmaceutical | Best Review Paper Award-7740

Dr. Eni Bushi | Pharmaceutical | Best Review Paper Award

Dr. Eni Bushi | Pharmaceutical – PhD student at University of Medicine Tirana, Albania

Eni Bushi (Beçi) is a dynamic pharmaceutical professional and researcher whose work bridges academia and the pharmaceutical industry. With extensive experience in pharmaceutical technology, quality assurance, and public health, she has made significant contributions both as a researcher and a leader in pharmaceutical practice. As the current Head of the Quality Assurance Department at Profarma sh.a. and a faculty member at the University of Medicine in Tirana, she plays a crucial role in shaping drug development standards and mentoring emerging professionals. A member of key scientific bodies such as NanoAlb and the Academy of Pharmacy “Eureka,” she exemplifies a strong commitment to advancing pharmaceutical knowledge through rigorous scientific inquiry and industry innovation.

Profile Verified

Scopus

Education

Eni Bushi holds a Master of Science in Pharmaceutical Sciences from the University of Medicine, Tirana, where she graduated with a perfect GPA and defended a thesis focused on prescription practices among elderly patients. Demonstrating her multidisciplinary outlook, she pursued a Master of Business Administration (MBA) at the University of New York Tirana, concentrating on healthcare management, with a thesis on Lean implementation in health systems. Currently, she is a PhD candidate in Pharmaceutical Technology at the same university, focusing on innovative semisolid formulations and their stability. Her academic journey has been enhanced by international certifications and professional development courses in nanotechnology, analytical validation, and Good Laboratory Practices.

Experience

Professionally, Eni Bushi has cultivated a strong career trajectory from community pharmacy to pharmaceutical manufacturing and research. Starting as a community pharmacist, she developed early experience in patient care and medication management. She then transitioned to Profarma sh.a., where she rose from Specialist to Head of the Quality Assurance Department, leading regulatory compliance, validation processes, and interdepartmental coordination. Simultaneously, she has served as a laboratory assistant and research mentor at the University of Medicine in Tirana. Her industry-academic hybrid role enables her to influence both pharmaceutical practice and education, while also fostering research innovation in drug development and regulatory science.

Research Interest

Eni Bushi’s research interests center on pharmaceutical technology, quality systems, antimicrobial resistance, and health systems improvement. Her current doctoral research focuses on semisolid drug formulations, with an emphasis on their physicochemical stability and comparative efficacy. She is particularly interested in integrating nanotechnology into drug delivery systems, and has pursued specialized training in nanomedicine. Her previous studies have explored the knowledge and behavior surrounding antibiotic use, as well as Lean strategies in healthcare environments. These interdisciplinary themes reflect her goal of advancing public health outcomes through innovation in drug formulation and pharmaceutical services.

Awards

Throughout her academic and professional journey, Eni Bushi has received recognition for her academic excellence and leadership. She was awarded the “Excellent Student” distinction by the University of Tirana’s Rectorate and has been consistently invited to contribute to international forums and scientific conferences. Her nomination for the Best Review Paper Award is underpinned by a record of impactful publications, academic mentorship, and a leadership role in pharmaceutical quality assurance.

Selected Publications

  1. 📘 Evaluation of the Knowledge, Attitude and Public Awareness about the Use of Antibiotic and Antibiotic Resistance in Albania (2024) – Indian Journal of Pharmaceutical Education and Research. Cited by 6 articles.
  2. 🧴 Formulation, Preparation and Evaluation of a Natural Cosmetic Product (2023) – Albanian Journal of Medical and Health Sciences. Cited by 3 articles.
  3. 🏥 Using Expert Consensus to Evaluate the Readiness Factors of Lean Implementation in Healthcare (2022) – International Journal of Scientific Research and Management. Cited by 9 articles.
  4. 👵 Prevalence and Factors Associated with Potentially Inappropriate Prescriptions among Older Patients at Hospital Discharge in Albania (2016) – Journal of Evaluation in Clinical Practice. Cited by 28 articles.
  5. 🧪 Theoretical Aspects of the Application of “Quality by Design” Approach in Drug Formulation (2025, Thesis Supervision) – Unpublished.
  6. 💊 Prevalence Assessment and Analysis of Self-Reported Use of Stimulant and Sedative Drugs among University Students (2023, Thesis Supervision) – University of Medicine, Tirana.
  7. 🧬 Analysis on the Level of Knowledge, Attitude, and Public Awareness Towards the Use of Antibiotics and Antimicrobial Resistance (2021, Thesis Supervision) – University of Medicine, Tirana.

Conclusion

Eni Bushi demonstrates a strong and evolving profile as a researcher, practitioner, and academic leader in the field of pharmaceutical sciences. Her combined background in pharmacy, business management, and pharmaceutical technology positions her uniquely to contribute to transformative change in drug formulation, health policy, and quality assurance. Her dedication to innovation, public health, and regulatory science makes her a highly deserving candidate for the Best Review Paper Award. Her work not only exemplifies academic excellence but also provides practical value to both the pharmaceutical industry and healthcare systems in Albania and beyond.

Dr. Charles Gaillard | Health Professions | Best Researcher Award

Dr. Charles Gaillard | Health Professions | Best Researcher Award

Dr. Charles Gaillard, Centre Hospitalier Regional et Universitaire de Tours, France

Dr. Charles Gaillard is a dedicated urologist currently completing his medical training with a focus on transplantation and genitourinary oncology. He holds a series of advanced diplomas, including a Diplôme Inter-Universitaire in Oncologie Génito-Urinaire and a Thèse d’Exercice in Medicine, which he defended in 2022 on the topic of renal transplantation and drainage. Dr. Gaillard’s research, particularly his study on the necessity of drainage in renal transplantation, was published in FJUROL in August 2024 and awarded the Silver Medal with Honors from the jury. He has gained extensive clinical experience through internships at leading hospitals in Lyon and Tours, working under prominent professors in urology and vascular surgery.

Professional Profile:

Scopus

Suitability for the Award:

Dr. Gaillard’s research aligns well with the Best Researcher Award, especially given his focus on transplantation, surgical innovation, and urological treatment methodologies. His work contributes both to scientific understanding and practical advances in post-operative patient care, making a meaningful impact in his field.

Academic Background:

Dr. Charles Gaillard earned several prestigious diplomas in his field, including a Diplôme Inter-Universitaire in Genito-Urinary Oncology (2023), Thesis in Medicine on Renal Transplantation (2022), and Diplôme Universitaire in Urinary Lithiasis (2020). He has undergone specialized training in organ transplantation and urology across top institutions such as Sorbonne University and Paris-Lyon-Tours.

Clinical Experience:

Dr. Gaillard’s internship includes comprehensive work at Hôpital Edouard Herriot, Hôpital Bretonneau, and Clinique du Pôle Léonard de Vinci, where he honed his skills in urology, vascular surgery, and renal transplantation under expert supervision.

Research Focus & Achievements:

His doctoral thesis on renal transplantation—titled “Is Redon Drainage Essential in Renal Transplantation?”—was published in FJUROL (2024) and won the Silver Medal with Jury Honors. The study explored risk factors associated with the necessity of drainage in renal transplant surgeries.

Honors & Recognition:

Dr. Gaillard’s dedication to research and clinical excellence has earned him recognition in his field, including Medal of Silver with Jury Congratulations for his groundbreaking research on transplantation.

Publication Top Notes:

  • Cut-off time for surgery and prediction of orchiectomy in spermatic cord torsion: a retrospective multicentric study over 15 years
    • Journal: World Journal of Urology, 2023,
    • Citations: 2
  • Torsion of the spermatic cord in adults: a multicenter experience in adults with surgical exploration for acute scrotal pain with suspected testicular torsion
    • Journal: Asian Journal of Andrology, 2022,
    • Citations: 7
  • TORSAFUF – Surgical exploration for torsion of spermatic cord suspicion and risk factors for unnecessary surgery: Results of a French nationwide retrospective study on 2940 patients
    • Journal: Progres en Urologie, 2022
    • Citations: 2
  • Contralateral Orchiopexy at the Time of Urgent Scrotal Exploration-Is It Safe? A Propensity Score Matched Analysis from the TORSAFUF Cohort
    • Journal: Journal of Urology, 2021
    • Citations: 5